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Abstract The X-ray crystal structure of the serpin^proteinase
complex suggested that the serpin deformed the proteinase
thereby inactivating the molecule. Using a variant of K1-
antitrypsin in which both tryptophan residues have been replaced
by phenylalanine, we have shown that the proteinase becomes
partially unfolded during serpin inhibition. The tryptophan free
variant, K1-antitrypsinFF, is fully active as an inhibitor of
thrombin. Thrombin has a fluorescence emission maximum of
340 nm which blue shifts to 346 nm, concomitant with a 40%
increase in intensity, upon formation of the serpin^proteinase
complex indicative of substantial conformational change within
the proteinase. Stopped-flow analysis of the fluorescence changes
within the proteinase indicated a two-step mechanism. A fast
bimolecular reaction with a rate constant of 2.8U106 M31 s31 is
followed by a slow unimolecular process with a rate of 0.26 s31
that is independent of concentration. We propose that the first
rate is formation of an initial complex which is then followed
by a slower process involving the partial unfolding of the
proteinase during its translocation to the opposite pole of the
serpin. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The serpin (serine proteinase inhibitor) superfamily of pro-
teins control a wide range of physiological events such as
coagulation, complement activation and apoptosis [1]. While
many serpins function primarily as serpins it has recently been
demonstrated that some are also inhibitors of cysteine pro-
teinases [2,3]. The crystal structures of a number of serpins are
known and they all conform to a standard architecture con-
sisting of a core of three L-sheets surrounded by nine K-helices
[4^10]. Protruding from the A L-sheet is the reactive center
loop, a stretch of amino acid residues which contains the
scissile bond. The primary sequence of this region plays the
major role in determining serpin inhibitory speci¢city [11].
The simplest kinetic scheme which describes the serpin pro-
teinase interaction is:
E IHK31 EIMÿ!k2 EI Scheme 1
Where K31 is the equilibrium dissociation constant for the
Michaelis-type complex and k2 is the rate constant for the
pseudo-irreversible or irreversible transformation of EIM
into EI*, the ¢nal inhibited complex.
The nature of the serpin-speci¢c conformational changes
involved in each of these steps is controversial. Ourselves
and others have shown that formation of EIM involves partial
insertion of the reactive center loop into the A L-sheet of the
serpin [12,13], whereas Gettins and co-workers have recently
shown that nuclear magnetic resonance (NMR) data suggest
that no change occurs in the serpin [14]. The transformation
from EIM to EI*, which probably involves a number of steps,
results in the translocation of the proteinase to the opposite
pole of the molecule. The recently solved crystal structure of a
serpin^proteinase complex clearly demonstrates that the reac-
tive center loop is fully inserted into the A L-sheet [10], con-
sistent with this movement. Two studies using biophysical
techniques and epitope mapping, however, contrast with these
structural data and suggest that the ¢nal complex is an en-
semble of conformations in which the reactive center loop is
in an equilibrium between partial and full insertion [15,16]. It
is the inherent instability of the serpin molecule that drives
this substantial conformational change [17], such that protein-
ase inhibition results in a marked increase in the stability of
the serpin [18]. The ability to undergo such conformational
changes also makes the serpin molecule extremely susceptible
to mutations that result in inappropriate conformational
changes which can cause diseases such as emphysema, throm-
bosis and liver disease [19,20].
Whilst the conformational changes within the serpin have
been intensively studied, little work has focused on proteinase
conformational change. 1H NMR studies have indicated that
conformational changes occur in the proteinase active site
[18,21]. It has also been demonstrated that the proteolytic
vulnerability of certain loops within the proteinase is in-
creased in the serpin^enzyme complex compared with the un-
inhibited state, suggesting conformational change [18,22,23].
The crystal structure of the serpin^proteinase complex con-
¢rmed these ¢ndings, indicating that the proteinase had be-
come partially disordered, based upon the lack of electron
density for 37% of the structure [10].
In order to characterize the proteinase conformational
change further we have utilized £uorescence spectroscopy,
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which is an extremely sensitive technique that can be used to
follow both protein folding and binding events. Interpretation
of £uorescence data is di⁄cult, however, if both proteins pos-
sess tryptophan residues, as the origin of any signal change is
unclear. We have replaced the two tryptophan residues of K1-
antitrypsin (K1-AT) with phenylalanine to create a £uores-
cently silent variant of K1-AT that is fully active as an inhib-
itor. This has allowed for the ¢rst time direct observation of
the conformational changes in the proteinase during serpin
inhibition. Our data strongly suggest a two-step mechanism
in which substantial proteinase unfolding occurs during the
transformation of EIM to EI*.
2. Materials and methods
2.1. Production and characterization of K1-ATFF
In this study we used the Pittsburgh variant (where the P1 = Arg) of
K1-AT as our template for mutagenesis. K1-ATP1Arg contains two
tryptophan residues numbered 194 and 238, which were replaced by
phenylalanine residues using the Quick change site-directed mutagen-
esis kit (Stratagene) to produce K1-ATFF. The mutations were veri-
¢ed using DNA sequencing. K1-ATFF was expressed in Escherichia
coli as inclusion bodies and puri¢ed as previously described [24]. The
association rate constant (kass) and stoichiometry of inhibition (SI) for
the interaction of K1-ATFF with thrombin were determined as de-
scribed previously [25].
2.2. Production and characterization of thrombin
Thrombin was puri¢ed from human plasma and characterized as
previously described [26].
2.3. Spectroscopic experiments
All £uorescence experiments were performed in a 50 mM Tris, pH
7.8, 0.1 M NaCl bu¡er at 25‡C using a Perkin Elmer LS50B spectro-
£uorimeter. Emission spectra were recorded between 300 and 400 nm
(Vex = 280 nm) at scan rates of 1 nm/s with slit widths of 2.5 nm for
both excitation and emission.
2.4. Circular dichroism (CD)
CD experiments were performed on a Jasco 820s spectropolarimeter
using a protein concentration of 0.05 mg/ml in 50 mM Tris, 100 mM
NaCl, pH 7.8. Thermal unfolding was performed using a heating rate
of 60‡C/h and the changes in secondary structure with temperature
were measured by monitoring the CD signal at 222 nm.
2.5. Kinetic experiments
All kinetic experiments were performed using an Applied Photo-
physics SF.18MV stopped-£ow apparatus. The proteinase conforma-
tional change was monitored by following changes in £uorescence
intensity (Vex = 290 nm) at wavelengths s 320 nm using a cut-o¡ ¢lter
placed between the reaction cell and the detector. Equal volumes of
proteinase and serpin were rapidly mixed at 25‡C under pseudo-¢rst
order conditions and the reaction followed. Both solutions contained
50 mM Tris, 0.1 M NaCl, pH 7.8. Data collected from at least eight
traces were averaged and ¢tted to either a single or double exponen-
tial function using the manufacturer’s software.
3. Results
The recent structure of the serpin^proteinase complex pro-
vided direct structural evidence that during inhibition the pro-
teinase becomes partially distorted [10]. The aim of this work
was to determine in solution the extent and kinetics of this
conformational change using £uorescence spectroscopy. To
achieve this we created a £uorescently silent K1-AT variant
(K1-ATFF) in which both native tryptophan residues (194
and 238) were replaced by phenylalanine. We chose the Pitts-
burgh variant of K1-AT for these studies as numerous studies
have shown that this serpin variant functions as a classic
serpin, inhibiting thrombin with high e⁄ciency [12,14,27].
Due to the replacement of both tryptophan residues (in par-
ticular Trp-194 which is conserved within 94% of the serpin
superfamily [28]) we characterized the stability and activity of
K1-ATFF. The far-UV CD spectrum of K1-ATFF was iden-
tical to that of wild-type antitrypsin (data not shown), indi-
cating that the mutations had not signi¢cantly altered the
serpin’s structure and that the tryptophan residues did not
contribute to the far-UV spectrum. The stability of the serpin
was assessed using a thermal melt yielding a melting temper-
ature of 58‡C, similar to that of the wild-type (Table 1). K1-
ATFF displayed a SI of 1.2, which was con¢rmed by the
presence of a small amount of cleaved material seen in sodium
dodecyl sulfate^polyacrylamide gel electrophoresis analysis of
the complex (Table 1; insert to Fig. 1) and a kass of 6U105
M31 s31 with thrombin, indicating that the double mutation
had no signi¢cant e¡ect upon the inhibitory characteristics of
the protein (Table 1).
The phenylalanine substitutions, however, had dramatic ef-
fects upon the emission spectra of K1-ATFF (Fig. 1). K1-AT
normally has an emission maximum at 337 nm (Vex = 280 nm),
indicative of its two partially buried tryptophan residues,
whereas K1-ATFF possesses an emission maximum of 308
nm (Vex = 280 nm), indicative of a protein totally devoid of
tryptophan residues (Fig. 1). The native state of thrombin has
an emission maximum at 340 nm, which represents a global
picture of the nine tryptophan residues in the thrombin mol-
ecule. Upon addition of equimolar amounts of K1-ATFF to
thrombin, the tryptophan emission maximum became red-
shifted to 346 nm concomitant with a 40% increase in £uo-
Table 1
Protein kassU105 (M31 s31) SI TM (‡C)
K1-ATP1Arg 4.9 þ 02 1.1 59.6 þ 0.3
K1-ATFF 6.7 þ 0.15 1.2 57.9 þ 0.2
Fig. 1. Fluorescence emission spectra of thrombin and thrombin^
K1-ATFF complex. The £uorescence emission spectra of 200 nM
thrombin (dashed line), 200 nM K1-ATFF (dashed and dots), the
sum of thrombin and K1-ATFF spectra (solid line) and the throm-
bin^K1-ATFF complex (dashed line) are shown. The excitation
wavelength was 290 nm with a bandpass of 2.5 nm and a tempera-
ture of 25‡C. Each spectrum represents the average of ¢ve scans
and two di¡erent protein preparations. The inset shows the proteins
used for the spectra: 1 ^ K1-ATFF ; 2 ^ the complex between K1-
ATFF and thrombin and 3 ^ thrombin.
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rescence intensity. These changes are indicative of the trypto-
phan residues of thrombin becoming more solvent-exposed,
suggesting partial unfolding of the proteinase following inhi-
bition.
In order to further characterize this conformational change
we undertook stopped-£ow £uorescence studies to determine
the individual rate constants for the process. K1-ATFF and
thrombin were rapidly mixed under pseudo-¢rst order condi-
tions in which K1-ATFF was at a minimum of 7-fold molar
excess. A typical reaction progress curve obtained after mixing
is shown in Fig. 2A. The curve shows a rapid increase in
£uorescence intensity with a half-life of W30 ms followed
by a decrease in £uorescence intensity with a half-life of
W3.5 s. Analysis of the data obtained between 0.5 and 4.5
WM yielded both the rate constants (kobs1 and kobs2) and the
amplitudes for the two phases; the values obtained for the
rate constants are shown in Fig. 2B. The amplitudes of the
two phases did not vary signi¢cantly with the concentration of
K1-ATFF, the mean amplitudes of the ¢rst and second phases
were +0.09 and 30.18, respectively. Fig. 2B shows the depen-
dence of the observed rate constants on the concentration of
K1-ATFF. The rate of initial increase in £uorescence (kobs1)
was found to be linearly dependent on the concentration of
K1-ATFF, which is typical of a simple bimolecular interac-
tion. Analysis of the variation in kobs1 according to
kobs  k1Ik31 1
[29] where k1 is the apparent second order rate constant for
the formation of the initial serpin enzyme complex yields a
value of 2.8 þ 0.2U106 M31 s31. The concentration depen-
dence of kobs1 indicates that it is following conformational
changes within thrombin due to its binding to the serpin
and formation of EIM. The dissociation rate constant of the
initial complex, k31, was determined to be 5.5 þ 0.3 s31. The
equilibrium dissociation constant K31 of the EIM complex,
calculated from k1 and k31, was 0.51 WM.
kobs2, which describes the large decrease in £uorescence in-
tensity following formation of the docking complex, did not
vary signi¢cantly between 0.5 and 4.5 WM K1-ATFF. The lack
of variation in concentration dependency of kobs2 (weighted
mean for kobs2 was 0.26 þ 0.01 s31) indicates that the trans-
formation of EIM to the ¢nal complex is a ¢rst order, irre-
versible process. We propose that k2 reports a slow conforma-
tional change within the proteinase, following formation of
EIM, which leads to complete inhibition of the proteinase.
4. Discussion
4.1. Characterization of K1-ATFF
Throughout this study we have used the double tryptophan
knockout K1-ATFF in which both Trp-194 and -238 have
been replaced. K1-ATFF was found to be as stable as K1-
ATP1Arg and fully active against thrombin. This result is
signi¢cant because Trp-194, which is situated at the top of
the A L-sheet on strand 3A, is one of the most highly con-
served residues (94%) across the serpin superfamily [28].
Therefore, the double replacement results in a molecule with-
out £uorescence in the tryptophan region of the spectrum that
has retained full activity and stability.
4.2. Interpretation of the £uorescence changes
Using a £uorescently silent serpin we have begun to directly
probe the proteinase conformational changes that occur dur-
ing inhibition. Stopped-£ow analysis of the reaction identi¢ed
two phases, the ¢rst a rapid enhancement in £uorescence in-
tensity followed by a slower decrease. Thrombin possesses
nine tryptophan residues spread throughout the molecule
and the enhancement in £uorescence could be caused by a
change in exposure of one or more of them. It has previously
been shown that the intrinsic £uorescence of thrombin is in-
creased when it binds hirudin and other active site-speci¢c
inhibitors [30,31]. Analysis of the crystal structure of various
thrombin^inhibitor complexes and thermodynamic data sug-
gests that the environment of three tryptophan residues would
be signi¢cantly changed [32,33]. These residues Trp-60, Trp-96
and Trp-148 are all situated on £exible loops that surround
the active site. It has been proposed from the structure of
thrombin with BPTI that Trp-60 and Trp-148 on the 60-
Fig. 2. Reaction of thrombin with K1-ATFF. (A) Thrombin (0.1
WM) and K1-ATFF (4.5 WM) were rapidly mixed and the change in
£uorescence followed. The inset shows the initial increase in £uores-
cence occurring over the ¢rst 400 ms. The data were ¢tted to a sin-
gle exponential function to yield a value of 18.4 þ 0.3 s31. This is
followed by a decrease in intensity which was ¢tted to a single ex-
ponential decay to yield a value of 0.24 þ 0.02 s31. (B) Dependence
of the values for kobs on the concentration of K1-ATFF. Analysis
of the data similar to those shown in A yielded estimates for kobs1
(F) and kobs2 (R) ; these are plotted together with their standard er-
rors. The data for kobs1 were ¢tted to Eq. 1 and the line shows the
results of this analysis.
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and 148-loops would form stabilizing interactions with a ser-
pin during formation of the docking complex [32]. The initial
enhancement in £uorescence is concentration dependent (Fig.
2B), which suggests a bimolecular process. Given the previous
£uorescence data described above and our own we suggest
that the ¢rst step is formation of the initial docking complex
(EIM) which requires signi¢cant movement of thrombin’s
loops.
The second £uorescence change is a decrease in intensity.
This e¡ect is strongly suggestive of increased solvent exposure
of one or more of the tryptophan residues within thrombin.
Given the magnitude of the change and the large number of
tryptophan residues involved it is di⁄cult to assign any spe-
ci¢c structural changes.
Stopped-£ow analysis of the reaction between K1-ATFF
and thrombin has enabled us to directly monitor the confor-
mational changes within thrombin as it becomes inhibited.
Our data show that within less than 1 s after mixing an initial
complex EIM (which has increased £uorescence intensity) is
formed in a second order process. The rate constants charac-
terizing the formation and breakdown of EIM are 2.8U106
M31 s31 and 5.5 s31, respectively. These values agree ex-
tremely well with those determined by others [34]. This also
indicates that the use of K1-ATFF and thrombin represents a
good model for examining the serpin^proteinase interaction.
The second step of the reaction is a ¢rst order process that
results in a large decrease in £uorescence. k2 (0.2 s31) repre-
sents the rate of conversion of EIM to EI*. This value also
agrees well with the rate of translocation of the proteinase
from one pole of the molecule to another as observed by
others (0.13 s31 [34]).
This study follows the conformational changes observed
solely in the proteinase for the ¢rst time. As the deformation
of the proteinase occurs on the same time scale as transloca-
tion we propose that the proteinase becomes distorted during
its journey from one end of the serpin to the other. These
¢ndings support the hypothesis generated from the recent ser-
pin^proteinase crystal structure in which it is proposed that
the proteinase is ‘crushed’ against the body of the serpin as it
moves towards its ¢nal position [10]. This process is driven by
the ability of the serpin to rapidly insert its reactive center
loop residues into the body of the serpin. Interestingly recent
work has shown that the rate of insertion due to inappropri-
ate cleavage of the reactive center loop is approximately 10-
fold faster than when a proteinase is attached [35]. Carrell and
colleagues propose that the conformational change in the pro-
teinase is required for by-passing the F-helix which lies across
the A L-sheet [10]: here we provide direct spectroscopic data
to support this.
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